COMMUNIQUÉS West-GlobeNewswire

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05/04/2024 - 22:00

WESTLAKE VILLAGE, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology [...]

CDR-Life Unveils Results on T-Cell Engagers Targeting Hard-to-Treat Solid Tumors at AACR 2024

05/04/2024 - 21:00

Preclinical data shows promising anti-tumor activity and specificity for KK-LC-1/HLA-A*01 positive tumors ZÜRICH, Switzerland, April 05, 2024 (GLOBE NEWSWIRE) -- CDR-Life Inc. today announced the presentation of [...]

Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024

05/04/2024 - 21:00

- Multispecific CD73/PD-1 DFC demonstrates improved tumor reduction compared to PD-1 monotherapy in nonclinical study - CCR5-targeting DFC demonstrates potent efficacy in colorectal cancer mouse model - Late-breaking [...]

Araris Biotech AG Presents Data on Novel Antibody-Drug Conjugates at American Association for Cancer Research (AACR) Annual Meeting 2024

05/04/2024 - 21:00

Studies demonstrated novel ADCs combining two TOP1i payloads with different features have the potential to maximize ADC efficacy and improve therapeutic index AU ZH, Switzerland, April 05, 2024 (GLOBE NEWSWIRE) -- [...]

GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F

05/04/2024 - 20:00

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 5, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients [...]

GENFIT : Mise à disposition du Document d’Enregistrement Universel 2023 et du Rapport Annuel Form 20-F 2023

05/04/2024 - 20:00

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 5 avril 2024 – GENFIT (Nasdaq et Euronext: GNFT) , société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]

NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US

05/04/2024 - 19:35

CLOSED 6 BILLION DOLLAR SERIES B DEAL SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- Silicon Valley-based Neurotechnology Powerhouse, announced that it launched its non-invasive iBrain™ Personal Brain Monitor, in 4 [...]

EchoNous Announces Revolutionary AI Enhancements in Upcoming Kosmos Release for Apple iOS

05/04/2024 - 18:35

REDMOND, Wash., April 05, 2024 (GLOBE NEWSWIRE) -- EchoNous, a leading innovator in ultrasound technology, is thrilled to announce the upcoming Kosmos 2.2 release on Apple iOS, a monumental update enriched with powerful [...]

Availability of the 2023 Universal Registration Document, including the Annual Financial Report

05/04/2024 - 18:21

Press Release Paris – April 5, 2024 – EUROAPI announces the publication of its 2023 Universal Registration Document, filed with the French Autorité des marchés financiers (AMF) on April 5, 2024. The 2023 Universal [...]

Mise à disposition du Document d’Enregistrement Universel 2023, contenant le Rapport Financier Annuel

05/04/2024 - 18:21

Communiqué de presse Paris – Le 5 avril 2024 – EUROAPI annonce la publication de son Document d’Enregistrement Universel 2023, déposé auprès de l’Autorité des marchés financiers (AMF) le 5 avril 2024. Le Document d’ [...]

PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)

05/04/2024 - 18:00

Lyon (France) and Cambridge (MA, US), 5 April 2024 – 6:00pm CEST - PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial [...]

PHAXIAM Therapeutics annonce le dépôt de son Document d’Enregistrement Universel (URD) 2023

05/04/2024 - 18:00

Lyon (France) et Cambridge (MA, US), le 5 avril 2024 – 18h00 CEST – PHAXIAM Therapeutics (Euronext : PHXM ; FR0011471135) société biopharmaceutique qui développe des traitements innovants contre les infections [...]

Activation of PA Licensure Compact to Improve Access to Patient Care

05/04/2024 - 17:23

PA compact will eliminate unnecessary barriers to PA practice across state lines ALEXANDRIA, Va., April 05, 2024 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA), Federation of State Medical [...]

Theratechnologies Appoints Elina Tea to its Board of Directors

05/04/2024 - 17:00

MONTREAL, April 05, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of [...]

Theratechnologies nomme Elina Tea à son conseil d’administration

05/04/2024 - 17:00

MONTRÉAL, 05 avr. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au point et la commercialisation de [...]

Hapbee Received Commitments for $2.785 Million From Qualified Investors

05/04/2024 - 16:12

VANCOUVER, British Columbia, April 05, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company has announced on [...]

Medicovestor Selected as Finalist to Present Its First-in-Class ADC Platforms at JP Morgan Asset Management: Life Sciences Innovation Summit

05/04/2024 - 16:00

NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Medicovestor, Inc. has been chosen as one of 11 finalists from a competitive pool of over 150 applicants spanning more than 20 countries to showcase its innovative Antibody- [...]

HiberCell Announces Recent Publication and Poster Presentations for its Novel GCN2 Activator, HC-7366

05/04/2024 - 16:00

NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, today announced the publication of “ [...]

New Board Candidate for the upcoming Annual Geneal Meeting

05/04/2024 - 15:46

April 5, 2024 Announcement no. 7 New Board Candidate for the upcoming Annual Geneal Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, April 5, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an [...]